nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluoxymesterone—PRLR—ErbB4 signaling events—ERBB4—gallbladder cancer	0.145	0.145	CbGpPWpGaD
Fluoxymesterone—PRLR—Nuclear signaling by ERBB4—ERBB4—gallbladder cancer	0.133	0.133	CbGpPWpGaD
Fluoxymesterone—PRLR—ErbB4 signaling events—ERBB2—gallbladder cancer	0.0785	0.0785	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling by ERBB4—ERBB4—gallbladder cancer	0.0447	0.0447	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling events mediated by PTP1B—EGFR—gallbladder cancer	0.0396	0.0396	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling by ERBB4—ERBB3—gallbladder cancer	0.0387	0.0387	CbGpPWpGaD
Fluoxymesterone—SHBG—Nongenotropic Androgen signaling—HRAS—gallbladder cancer	0.0379	0.0379	CbGpPWpGaD
Fluoxymesterone—ESR1—Nuclear signaling by ERBB4—ERBB4—gallbladder cancer	0.0249	0.0249	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling by ERBB4—ERBB2—gallbladder cancer	0.0242	0.0242	CbGpPWpGaD
Fluoxymesterone—ESR1—Estrogen signaling pathway—BCL2—gallbladder cancer	0.0212	0.0212	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—KEAP1—gallbladder cancer	0.0189	0.0189	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling by ERBB4—NRAS—gallbladder cancer	0.0184	0.0184	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling by ERBB4—EGFR—gallbladder cancer	0.0168	0.0168	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling by ERBB4—KRAS—gallbladder cancer	0.0159	0.0159	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling by ERBB4—HRAS—gallbladder cancer	0.0135	0.0135	CbGpPWpGaD
Fluoxymesterone—AR—Nongenotropic Androgen signaling—HRAS—gallbladder cancer	0.0117	0.0117	CbGpPWpGaD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—NRAS—gallbladder cancer	0.0113	0.0113	CbGpPWpGaD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—BCL2—gallbladder cancer	0.00999	0.00999	CbGpPWpGaD
Fluoxymesterone—ESR1—Plasma membrane estrogen receptor signaling—NRAS—gallbladder cancer	0.00988	0.00988	CbGpPWpGaD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—KRAS—gallbladder cancer	0.00974	0.00974	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—NRAS—gallbladder cancer	0.00901	0.00901	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—ERBB4—gallbladder cancer	0.00896	0.00896	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—gallbladder cancer	0.00858	0.00858	CbGpPWpGaD
Fluoxymesterone—ESR1—Plasma membrane estrogen receptor signaling—KRAS—gallbladder cancer	0.0085	0.0085	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—ERBB4—gallbladder cancer	0.0084	0.0084	CbGpPWpGaD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—HRAS—gallbladder cancer	0.00828	0.00828	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—EGFR—gallbladder cancer	0.00821	0.00821	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—ERBB2—gallbladder cancer	0.00801	0.00801	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—KRAS—gallbladder cancer	0.00776	0.00776	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—ERBB3—gallbladder cancer	0.00775	0.00775	CbGpPWpGaD
Fluoxymesterone—ESR1—LKB1 signaling events—TP53—gallbladder cancer	0.00728	0.00728	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—ERBB3—gallbladder cancer	0.00726	0.00726	CbGpPWpGaD
Fluoxymesterone—ESR1—Plasma membrane estrogen receptor signaling—HRAS—gallbladder cancer	0.00723	0.00723	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—HRAS—gallbladder cancer	0.00659	0.00659	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—EGFR—gallbladder cancer	0.00629	0.00629	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—BCL2—gallbladder cancer	0.00612	0.00612	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—EGFR—gallbladder cancer	0.00601	0.00601	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—ERBB4—gallbladder cancer	0.00579	0.00579	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—BCL2—gallbladder cancer	0.00507	0.00507	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—ERBB3—gallbladder cancer	0.00501	0.00501	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—BCL2—gallbladder cancer	0.005	0.005	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—TP53—gallbladder cancer	0.00493	0.00493	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—ERBB2—gallbladder cancer	0.00492	0.00492	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—ERBB2—gallbladder cancer	0.00486	0.00486	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—TP53—gallbladder cancer	0.00485	0.00485	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—BCL2—gallbladder cancer	0.00471	0.00471	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—ERBB2—gallbladder cancer	0.00455	0.00455	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—HRAS—gallbladder cancer	0.00446	0.00446	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—TP53—gallbladder cancer	0.00427	0.00427	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—EGFR—gallbladder cancer	0.00412	0.00412	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—BCL2—gallbladder cancer	0.0039	0.0039	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—KRAS—gallbladder cancer	0.00389	0.00389	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—ERBB2—gallbladder cancer	0.00379	0.00379	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—NRAS—gallbladder cancer	0.0037	0.0037	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—NRAS—gallbladder cancer	0.00346	0.00346	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—TP53—gallbladder cancer	0.00346	0.00346	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—EGFR—gallbladder cancer	0.00341	0.00341	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—EGFR—gallbladder cancer	0.00337	0.00337	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—KRAS—gallbladder cancer	0.00322	0.00322	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—KRAS—gallbladder cancer	0.00318	0.00318	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—EGFR—gallbladder cancer	0.00317	0.00317	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—EGFR—gallbladder cancer	0.00316	0.00316	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—ERBB2—gallbladder cancer	0.00314	0.00314	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—KRAS—gallbladder cancer	0.003	0.003	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—KRAS—gallbladder cancer	0.00298	0.00298	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—TP53—gallbladder cancer	0.00286	0.00286	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—HRAS—gallbladder cancer	0.0027	0.0027	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—TP53—gallbladder cancer	0.00266	0.00266	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—gallbladder cancer	0.00263	0.00263	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—HRAS—gallbladder cancer	0.00253	0.00253	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—gallbladder cancer	0.00248	0.00248	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—NRAS—gallbladder cancer	0.00239	0.00239	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—TP53—gallbladder cancer	0.00221	0.00221	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—EGFR—gallbladder cancer	0.00218	0.00218	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—KRAS—gallbladder cancer	0.00206	0.00206	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—TP53—gallbladder cancer	0.00183	0.00183	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—HRAS—gallbladder cancer	0.00175	0.00175	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—ERBB4—gallbladder cancer	0.00109	0.00109	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—ERBB3—gallbladder cancer	0.00094	0.00094	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—ERBB2—gallbladder cancer	0.00059	0.00059	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NRAS—gallbladder cancer	0.000449	0.000449	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—EGFR—gallbladder cancer	0.000409	0.000409	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—KRAS—gallbladder cancer	0.000386	0.000386	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TP53—gallbladder cancer	0.000343	0.000343	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—HRAS—gallbladder cancer	0.000328	0.000328	CbGpPWpGaD
